Table 2.
———–SHFS ———– | ———–SHS ———– | ———Meta-analysis——— | |||||||
---|---|---|---|---|---|---|---|---|---|
GMR* | 95% CI | P^ | GMR* | 95% CI | P^^ | GMR* | 95% CI | P^^^ | |
14,15-EET | 1.04 | (1.01, 1.08) | 0.02 | 0.99 | (0.93, 1.06) | 0.85 | 1.03 | (1.00, 1.06) | 0.05 |
11,12-EET | 1.05 | (1.01, 1.09) | 0.01 | 0.98 | (0.92, 1.04) | 0.51 | 1.03 | (1.00, 1.06) | 0.07 |
8,9-EET | 1.04 | (1.01, 1.08) | 0.02 | 0.97 | (0.91, 1.03) | 0.30 | 1.03 | (1.00, 1.06) | 0.11 |
5,6-EET | 1.04 | (1.00, 1.08) | 0.03 | 0.95 | (0.89, 1.02) | 0.19 | 1.02 | (0.99, 1.05) | 0.18 |
14,15-DHET | 0.94 | (0.90, 0.97) | 0.001 | 0.92 | (0.86, 0.99) | 0.03 | 0.93 | (0.90, 0.97) | 2.0×10−05 |
11,12-DHET | 0.97 | (0.93, 1.00) | 0.08 | 0.95 | (0.87, 1.04) | 0.26 | 0.97 | (0.93, 1.00) | 0.04 |
8,9-DHET | 1.03 | (0.99, 1.07) | 0.14 | 0.96 | (0.89, 1.04) | 0.29 | 1.02 | (0.98, 1.05) | 0.37 |
5,6-DHET | 1.01 | (0.95, 1.07) | 0.74 | 0.92 | (0.85, 1.00) | 0.04 | 0.98 | (0.93, 1.02) | 0.32 |
Abbreviations: EET=Epoxyeicosatrienoic Acid; DHET= Dihydroxyeicosatrieonic acid; SHFS= Strong Heart Family Study; SHS= Strong Heart Study
The analyses were conducted in 1161 participants in the SHFS and 271 participants in the SHS and included adjustments for age, sex, site, education, smoking, physical activity, BMI (Kg/m2), waist circumference and LDL levels. Results from the two cohorts were combined in meta-analyses.
GMR: Geometric mean ratios of plasma insulin associated with one SD higher log EET/DHET species.
Inverse probability-of-being-sampled weighted Generalized Estimating Equations (GEE) regression Wald test with robust sandwich variance-covariance under a family-cluster-specific exchangeable working correlation structure, and results from multiple imputations combined using Rubin's rules
Linear regression Wald test with robust standard errors and results from multiple imputations combined using Rubin's rules.
Inverse-variance weighted fixed-effects meta analysis.